English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006. 2. Arpin C, Dubois V, Coulange L et al. Extended-spectrum b-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 2003; 47: 3506–14. 3. De Gheldre Y, Avesani V, Berhin C et al. Evaluation of Oxoid combination discs for detection of extended-spectrum b-lactamases. J Antimicrob Chemother 2003; 52: 591–7. 4. Jeong SH, Bae IK, Kwon SB et al. Dissemination of transferable CTX-M-type extended-spectrum b-lactamase-producing Escherichia coli in Korea. J Appl Microbiol 2005; 98: 921–7. 5. Paterson DL, Bonomo RA. Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657–86. 6. Pitout JD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52–9. 7. Rodriguez-Bano J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum b-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089–94. 8. Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum b-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769–75. 9. Andres P, Petroni A, Faccone D et al. Extended-spectrum b-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int J Antimicrob Agents 2005; 25: 501–7. 10. Kim S, Kim J, Kang Y et al. Occurrence of extended-spectrum b-lactamases in members of the genus Shigella in the Republic of Korea. J Clin Microbiol 2004; 42: 5264–9.

Marked increase in steady-state serum levels achieved with itraconazole oral solution compared with capsule formulation